- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Target engagement imaging of PARP inhibitors in small-cell lung cancer ; volume:9 ; number:1 ; day:12 ; month:1 ; year:2018 ; pages:1-13 ; date:12.2018
Nature Communications ; 9, Heft 1 (12.1.2018), 1-13, 12.2018
- Schlagwort
-
Krebs
Onkologie
- Urheber
-
Carney, Brandon
- Beteiligte Personen und Organisationen
-
Kossatz, Susanne
Lok, Benjamin H.
Schneeberger, Valentina
Gangangari, Kishore K.
Pillarsetty, Naga Vara Kishore
Weber, Wolfgang Andreas
Rudin, Charles M.
Poirier, John T.
Reiner, Thomas
SpringerLink (Online service)
- DOI
-
10.1038/s41467-017-02096-w
- URN
-
urn:nbn:de:1111-20180326160
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Carney, Brandon
- Kossatz, Susanne
- Lok, Benjamin H.
- Schneeberger, Valentina
- Gangangari, Kishore K.
- Pillarsetty, Naga Vara Kishore
- Weber, Wolfgang Andreas
- Rudin, Charles M.
- Poirier, John T.
- Reiner, Thomas
- SpringerLink (Online service)
Ähnliche Objekte (12)
PARP inhibitors
Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance
Advances and perspectives of PARP inhibitors
PARP Inhibitors in Ovarian Cancer: A Review
PARP inhibitors in the treatment of ovarian cancer
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
PARP Inhibitors in Breast Cancer: a Short Communication
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Advances in using PARP inhibitors to treat cancer
Prostate cancer and PARP inhibitors: progress and challenges
New treatment option for ovarian cancer: PARP inhibitors
PARP inhibitors in gastric cancer: beacon of hope
PARP inhibitors
Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance
Advances and perspectives of PARP inhibitors
PARP Inhibitors in Ovarian Cancer: A Review
PARP inhibitors in the treatment of ovarian cancer
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
PARP Inhibitors in Breast Cancer: a Short Communication
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Advances in using PARP inhibitors to treat cancer
Prostate cancer and PARP inhibitors: progress and challenges
New treatment option for ovarian cancer: PARP inhibitors
PARP inhibitors in gastric cancer: beacon of hope
PARP inhibitors
Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance
Advances and perspectives of PARP inhibitors
PARP Inhibitors in Ovarian Cancer: A Review
PARP inhibitors in the treatment of ovarian cancer
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
PARP Inhibitors in Breast Cancer: a Short Communication
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology
Advances in using PARP inhibitors to treat cancer
Prostate cancer and PARP inhibitors: progress and challenges
New treatment option for ovarian cancer: PARP inhibitors